 |

|
Publications:
|
» |
(9/28/05) Testimony before the Senate Special Committee on Aging on The Impact of Direct-to-Consumer Drug Advertising on Seniors’ Health and Health Care Costs (HRG Publication #1751)
|
» |
(7/25/05) Letter to FDA concerning FDA-approved Medication Guides (HRG Publication #1746)
|
» |
(7/29/04) Drug ads masquerading as news: letter to 258 local television station general managers and news directors in the country's top-30 television markets (HRG Publication #1702)
|
» |
(9/25/03) Letter to FDA concerning potentially dangerous patient information on Hormone Replacement Therapy (HRG Publication #1677)
|
» |
(9/11/03) Food and Drug Disaster. OpEd appearing in Washington Post on September 10, 2003 (HRG Publication #1676)
|
» |
(7/30/03) Comments by Sidney M. Wolfe, M.D and Larry D. Sasich, Pharm.D., M.P.H. before FDA Hearing on
Current Status of Useful Written Prescription Drug Information for Consumers, July 31, 2003 (HRG Publication #1672)
|
» |
(4/8/03) Lawsuit Settled: Government Agrees to Follow Law, Take Steps Toward Useful Patient Drug Information Program (HRG Publication #1661)
|
» |
(7/17/02) Comments before FDA Drug Safety Advisory Committee on Patient Drug Information (HRG Publication #1629)
|
» |
(5/22/02) Statement at FDA Hearing on Risk Management of Prescription Drugs (HRG Publication #1620)
|
» |
(4/30/02) Article in JAMA: Timing of new black box warnings and withdrawals for prescription medications (HRG Publication #1618)
|
» |
(2/29/00) Comments on a Food and Drug Administration survey on the status of useful written prescription drug information for patients, requesting that it be redesigned. (HRG Publication #1512)
|
» |
(1/1/00) Worst Pills, Best Pills
|
» |
(6/1/99) Letter to the Editor in the Washington Post concerning dangerous drug information found on their web site entitled InteliHealth which is associated with Johns Hopkins University. (HRG Publication #1484)
|
» |
(5/21/99) Statement concerning Senator Crapo's legislation that could keep patients in the dark about risks of prescription drugs. (HRG Publication #1482)
|
» |
(6/9/98) Petition to the Food and Drug Administration to immediately stop the distribution of dangerous, misleading prescription drug information to the public. (HRG Publication #1442)
|
» |
(8/21/97) Statement on misleading direct-to-consumer advertising by Schering for loratadine (Claritin). (HRG Publication #1426)
|
» |
(12/20/95) HRG Comments on Prescription Drug Product Labeling; Medical Guide Requirements (HRG Publication #1382)
|
|
more resources

Because Public Citizen does not accept funds from corporations, professional associations or government agencies,
we can remain independent and follow the truth wherever it may lead. But that means we
depend on the generosity of concerned citizens like you for the resources to fight on
behalf of the public interest. If you would like to help us in our fight,
click here.
|
 |